A Long Term Study of GK530G in Subjects With Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Acne Vulgaris
Interventions
DRUG

GK530G

Trial Locations (16)

Unknown

Galderma investigational site, Urayasu

Galderma investigational site, Fukuoka

Galderma investigational site, Kawasaki

Galderma investigational site, Yamato

Galderma investigational site, Yokohama

Galderma investigational site, Kumagaya

Galderma investigational site, Chiyoda City

Galderma investigational site, Koto

Galderma investigational site, Machida

Galderma investigational site, Musashino

Galderma investigational site, Ōta-ku

Galderma investigational site, Shibuya City

Galderma investigational site, Shinjuku

Galderma investigational site, Suginami

Galderma investigational site, Tachikawa

Galderma investigational site, Kōtō City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY